Catalyst Wire Dossier Catalyst Wire Dossier

Rituximab Mabion

rituximab · Mabion Spolka Akcyjna
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rituximab Mabion, covering 2020-06-24 to 2020-06-24. Get the full timeline:

Most recent: EMA Application withdrawn: Rituximab Mabion (rituximab) — Mabion Spolka Akcyjna

See pricing